June 13 (SeeNews) - Croatian pharmaceuticals producer Jadran Galenski Laboratorij (JGL) [ZSE:3JDG2] said on Thursday it will distribute a dividend of 4.0 euro ($4.33) per share from its retained profits for 2010 and 2011.
The company’s net profit of 13.08 million euro for 2023 will be retained, the company said in a filing to the Zagreb bourse following its annual shareholders’ meeting on Wednesday.
Last year, the company paid a dividend of 3.0 euro per share out of its retained profits for 2009 and 2010.
Founded in 1991, JGL is one of the largest drug makers in Croatia, specialising in the production of sterile nose, eye and ear drop solutions. JGL operates in some 60 markets around the world.
($ = 0.925 euro)